📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
9%
💰 Capital Raise
18%
• Active ATM program with $400M remaining capacity
💹 Market Data
Market Cap$5.30B
Shares Outstanding96.67M
Float90.77M
Cash$1.09B
Debt$7.49M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 0.5% shares (2025Q4 vs prior)
254 institutional holders · 87.60M shares
#1
FMR LLC
8.92M shares
#2
Avoro Capital Advisors LLC
5.42M shares
#3
BlackRock, Inc.
5.10M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest4.15M
Days to Cover4.6
% of Float4.6%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2014
4
INSIDER TRANSACTION
Mar 13, 2026
4
INSIDER TRANSACTION
Mar 13, 2026
4
INSIDER TRANSACTION
Mar 13, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for XENE
📊 XENE FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 XENE Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.